FI964083A0 - Fusogeeniset liposomit ja menetelmät valmistaa ja käyttää niitä - Google Patents

Fusogeeniset liposomit ja menetelmät valmistaa ja käyttää niitä

Info

Publication number
FI964083A0
FI964083A0 FI964083A FI964083A FI964083A0 FI 964083 A0 FI964083 A0 FI 964083A0 FI 964083 A FI964083 A FI 964083A FI 964083 A FI964083 A FI 964083A FI 964083 A0 FI964083 A0 FI 964083A0
Authority
FI
Finland
Prior art keywords
lipid
outermost
lipid bilayer
liposome
bilayer
Prior art date
Application number
FI964083A
Other languages
English (en)
Swedish (sv)
Other versions
FI964083A (fi
Inventor
Austin Bailey
Pieter R Cullis
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of FI964083A0 publication Critical patent/FI964083A0/fi
Publication of FI964083A publication Critical patent/FI964083A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI964083A 1994-04-12 1996-10-11 Fusogeeniset liposomit ja menetelmät valmistaa ja käyttää niitä FI964083A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/003996 WO1995027478A1 (en) 1994-04-12 1994-04-12 Fusogenic liposomes and methods of making and using same

Publications (2)

Publication Number Publication Date
FI964083A0 true FI964083A0 (fi) 1996-10-11
FI964083A FI964083A (fi) 1996-10-11

Family

ID=22242444

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964083A FI964083A (fi) 1994-04-12 1996-10-11 Fusogeeniset liposomit ja menetelmät valmistaa ja käyttää niitä

Country Status (13)

Country Link
EP (1) EP0758883B1 (fi)
JP (1) JP3804025B2 (fi)
KR (1) KR100315132B1 (fi)
AT (1) ATE234605T1 (fi)
AU (1) AU689479B2 (fi)
CA (1) CA2187748C (fi)
DE (1) DE69432320T2 (fi)
DK (1) DK0758883T3 (fi)
ES (1) ES2196028T3 (fi)
FI (1) FI964083A (fi)
NO (1) NO318814B1 (fi)
NZ (1) NZ268146A (fi)
WO (1) WO1995027478A1 (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339069B1 (en) 1996-10-15 2002-01-15 Elan Pharmaceuticalstechnologies, Inc. Peptide-lipid conjugates, liposomes and lipsomal drug delivery
ATE244572T1 (de) * 1996-10-15 2003-07-15 Liposome Co Inc Peptid-lipid konjugate, liposomen und liposomale arzneimittelverabreichung
US6835395B1 (en) 1997-05-14 2004-12-28 The University Of British Columbia Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles
JP4656675B2 (ja) 1997-05-14 2011-03-23 ユニバーシティー オブ ブリティッシュ コロンビア 脂質小胞への荷電した治療剤の高率封入
US6613352B2 (en) 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
KR100737980B1 (ko) * 1999-08-27 2007-07-12 아이넥스 파머슈티컬스 코포레이션 사이토카인 분비 자극용 및 면역반응 유도용 조성물
EP1613285A2 (en) * 2003-03-31 2006-01-11 Alza Corporation Lipid particles having asymmetric lipid coating and method of preparing same
EP1852177B1 (en) * 2005-01-28 2014-02-26 Japan Science and Technology Agency Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof
US20100215582A1 (en) 2007-05-14 2010-08-26 Konica Minolta Holdings, Inc. Liposome and method for producing liposome
WO2011017297A2 (en) 2009-08-03 2011-02-10 The University Of North Carolina At Chapel Hill Biodegradable delivery system complexes for the delivery of bioactive compounds
PT3338765T (pt) 2009-12-01 2019-03-18 Translate Bio Inc Derivado de esteróide adequado para a administração de arnm em doenças genéticas humanas
BR112013031553A2 (pt) 2011-06-08 2020-11-10 Shire Human Genetic Therapies, Inc. composições, mrna que codifica para uma hgla e seu uso, uso de pelo menos uma molécula de mrna e um veículo de transferência e uso de um mrna que codifica para proteína exógena
EP2859102A4 (en) 2012-06-08 2016-05-11 Shire Human Genetic Therapies NUCLEASE RESISTANT POLYNUCLEOTIDES AND USES THEREOF
IL305374A (en) 2013-03-14 2023-10-01 Ethris Gmbh CFTR mRNA Assemblies and Related Methods and Uses
US9957499B2 (en) 2013-03-14 2018-05-01 Translate Bio, Inc. Methods for purification of messenger RNA
CA2928188A1 (en) 2013-10-22 2015-04-30 Shire Human Genetic Therapies, Inc. Mrna therapy for argininosuccinate synthetase deficiency
EP3574923A1 (en) 2013-10-22 2019-12-04 Translate Bio, Inc. Mrna therapy for phenylketonuria
ES2750661T3 (es) 2014-04-25 2020-03-26 Translate Bio Inc Métodos para la purificación de ARN mensajero
EP3585417B1 (en) 2017-02-27 2023-02-22 Translate Bio, Inc. Method of making a codon-optimized cftr mrna
IL270631B2 (en) 2017-05-16 2024-03-01 Translate Bio Inc Treatment of cystic fibrosis through the administration of mRNA with an optimal codon encoding ctfr
US11174500B2 (en) 2018-08-24 2021-11-16 Translate Bio, Inc. Methods for purification of messenger RNA

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946787A (en) * 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
JP2760355B2 (ja) * 1986-06-16 1998-05-28 ザ リポソーム カンパニー，インコーポレイテッド 不均整誘導リポソーム
JPH0395118A (ja) * 1989-09-07 1991-04-19 Green Cross Corp:The プロスタグランジン含有脂肪小体製剤
DE4013632A1 (de) * 1990-04-27 1991-10-31 Max Planck Gesellschaft Liposomen mit positiver ueberschussladung
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells

Also Published As

Publication number Publication date
DK0758883T3 (da) 2003-06-02
KR100315132B1 (ko) 2002-06-26
WO1995027478A1 (en) 1995-10-19
DE69432320D1 (de) 2003-04-24
NO964284D0 (no) 1996-10-09
FI964083A (fi) 1996-10-11
ATE234605T1 (de) 2003-04-15
CA2187748A1 (en) 1995-10-19
EP0758883B1 (en) 2003-03-19
AU7091594A (en) 1995-10-30
NO318814B1 (no) 2005-05-09
EP0758883A1 (en) 1997-02-26
ES2196028T3 (es) 2003-12-16
JP3804025B2 (ja) 2006-08-02
CA2187748C (en) 2007-04-10
NZ268146A (en) 1997-10-24
DE69432320T2 (de) 2003-12-04
NO964284L (no) 1996-10-09
JPH09511521A (ja) 1997-11-18
AU689479B2 (en) 1998-04-02

Similar Documents

Publication Publication Date Title
FI964083A0 (fi) Fusogeeniset liposomit ja menetelmät valmistaa ja käyttää niitä
AU1724097A (en) Lipids and their use, for example, in liposomes
DK433484D0 (da) Medikamentholdigt lipidvesikelpraeparat
EP0607118A4 (en) ADMINISTRATION SYSTEM FOR PHOSPHOLIPID.
ES2053678T3 (es) Procedimiento para preparar un medicamento con contenido de azelastina para la aplicacion nasal y/u ocular.
EP0171710A3 (en) Process for preparing liposome composition
ATE286718T1 (de) Temperatursensitive liposomale formulierung
ATE172636T1 (de) Liposomales verabreichungssystem für biologisch aktive stoffe
ES2149955T3 (es) Vesiculas con liberacion controlada de sustancias activas.
DE3577397D1 (de) Fluessige diclofenac-zubereitungen.
AU4711296A (en) Method for loading lipid vesicles
TR199902484T2 (xx) Biyolojik y�nden aktif maddeler ihtiva eden yap���c� mikrokaps�ller
DK0592446T3 (da) Fyldningsteknik til fremstilling af lægemiddelholdige liposomer
CA2117769A1 (en) Liposome composition
ES8608862A1 (es) Un procedimiento para estabilizar particulas micelares y aumentar su duracion en estado preparado.
CA2168260A1 (en) Biphasic Multilamellar Lipid Vesicles
DK0799035T3 (da) Emulsion egnet til indgivelse af et sphingolipid og anvendelse deraf
IT8125135A0 (it) Procedimento per l'idrolizzazione in sito di una membrana permeabile agli ioni di una cella elettrolitica utilizzante tale membrana.
DE69528170T2 (de) Intrazelluläre verabreichung therapeutischer sustanzenmittels virosomen
KR920002165A (ko) 리포좀 생성물
FI103178B (fi) Menetelmä vaikuttavaa ainetta sisältävien vesipohjaisten liposomisuspe nsioiden valmistamiseksi
Fujisawa et al. Action of drugs on liposomes with varying charges
Kusaka et al. Characterization of glutamate transport system in hydrophobic protein (H protein) of Bacillus subtilis
IONOPHORE et al. Laboratory of Experimental Medicine, Brussels University, Brussels, B-1000 (Belgium)

Legal Events

Date Code Title Description
MA Patent expired